Back to search
FDAFDA · Food and drugs·Recall number D-0292-2021

Progesterone Capsules, 200 mg, 100-count bottles, Rx Only, MADE IN FRANCE; Distributed by: Dr. Reddy's Laboratories, Inc., Princeton, NJ 08540; NDC 43598-350-01.

Published March 10, 2021 · Recall initiated: February 26, 2021

Summary

FDA records drug Class II recall D-0292-2021, published March 10, 2021 and initiated February 26, 2021. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Terminated; Reported quantity: 16,449 bottles; Lot: Batch # 1399851P1, Exp 02/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: Out-of-specification results observed for dissolution during stability testing.

What to do

Voluntary: Firm initiated · Letter

Get an email if PROGESTERONE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
PROGESTERONE
Manufacturer
Dr. Reddy's Laboratories, Inc.
Distributor
Nationwide in the USA
Lot
Batch # 1399851P1, Exp 02/2021
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Progesterone Capsules, 200 mg, 100-count bottles, Rx Only, MADE IN FRANCE; Distributed by: Dr. Reddy's Laboratories, Inc., Princeton, NJ 08540; NDC 43598-350-01. recalled?

Yes. FDA published recall D-0292-2021 on March 10, 2021. Reported hazard: Failed Dissolution Specifications: Out-of-specification results observed for dissolution during stability testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: PROGESTERONE.